HPV vaccine
The HPV vaccine is a preventive biological therapy designed to induce immunity against human papillomavirus, a common sexually transmitted virus that is causally linked to cervical cancer and other HPV-associated malignancies.
The HPV vaccine is a preventive biological therapy designed to induce immunity against human papillomavirus, a common sexually transmitted virus that is causally linked to cervical cancer and other HPV-associated malignancies. By stimulating the production of neutralizing antibody responses against selected HPV types, vaccination aims to reduce infection, persistent viral carriage, and downstream precancerous lesions such as CIN2+ and HPV16/18-associated disease. In public health practice, HPV vaccine is typically deployed in adolescents before exposure to the virus, although vaccination campaigns and acceptance studies also include girls, women, and other higher-risk groups.
Biologically and clinically, the HPV vaccine is most often discussed in the context of cervical cancer prevention, but recent work also considers its role in broader cancer prevention and in populations with distinct exposure risks or implementation barriers. Research has focused not only on immunogenicity and safety, but also on vaccine hesitancy, acceptability, uptake, and delivery strategies among adolescents, parents, caregivers, healthcare providers, educators, and specific groups such as female sex workers and gay, bisexual, and other men who have sex with men. These studies reflect both the vaccine’s preventive mechanism and the behavioral, social, and health-system factors that shape real-world impact.
Where the papers sit
31 papers from the last 6 months study HPV vaccine directly · updated from PubMed 6 Oct 2026
Study type 0 clinical trials · 12 observational · 17 human data · 2 unclassified
Themes one subject · 1 paradigm shift · 1 new direction
Those 31 are all about one subject.
-
HPV Vaccination Uptake and Policy
Access, confidence and policy design remain central to expanding HPV vaccination across countries and communities. Recurring barriers include limited knowledge, provider constraints, hesitancy, cost and weak delivery infrastructure, while supportive funding and national-program integration facilitate uptake. Interventions increasingly use tailored messaging, adolescent health services and coadministration with routine vaccines. Evidence also tracks real-world safety and possible reductions in head and neck cancer, but local context continues to shape implementation.
HPV vaccination is presented as cancer prevention beyond cervical disease and beyond female populations
The U.S. cohort study of vaccinated and unvaccinated people aged 9–45 years found substantially lower overall head and neck cancer risk, particularly oropharyngeal squamous cell carcinoma, after vaccination 42604649Aug. The TriNetX cohort study of vaccinated males aged 9–45 years likewise found lower risks of head and neck cancer and several other potentially HPV-associated cancers and precancerous lesions 42472496Jul. Together, these findings replace the predominantly cervical-cancer and female-centered frame with a broader account in which HPV vaccination is associated with protection against multiple cancers in males as well.
HPV vaccination is used as an audit target for demographic bias in generative-AI health recommendations
The fixed-prompt audit of ChatGPT-4o’s HPV vaccine recommendations across age and sex framings found that the system’s recommendation style varied sharply by demographic context, including much lower probabilities of strong recommendations for women than men aged 27–45 years 42629325Aug. This places HPV vaccination in a role absent from the other papers: not only as an intervention, policy, or object of uptake research, but as a probe for evaluating demographic inconsistency in an AI health-information system.
Papers
The 31 papers from the last 6 months that study HPV vaccine directly, newest first, by theme and by study type. Study types come from PubMed publication types and MeSH headings.
By theme
HPV Vaccination Uptake and Policy (31)
- Health care providers' perspectives on county-level barriers and facilitators to HPV vaccination: A socio-ecological approach (2022-2023). Human vaccines & immunotherapeutics · 5 Oct 2026 PMID 42832184
- Sociodemographic correlates of human papilloma virus (HPV) and cervical cancer knowledge among Saudi women: A nationwide assessment. Medicine · 2 Oct 2026 PMID 42826274
- Knowledge and attitudes of medical students about human papillomavirus (HPV) and HPV vaccine: A cross-sectional survey in Inner Mongolia, China. Human vaccines & immunotherapeutics · 28 Sept 2026 PMID 42802652
- Real-world safety data of human papillomavirus vaccines after marketing in Shandong, China, August 2017-October 2025. Human vaccines & immunotherapeutics · 25 Sept 2026 PMID 42788243
- Global policy determinants of national human papillomavirus vaccine introductions in 2006-2025. Expert review of vaccines · 22 Sept 2026 PMID 42770688
- HPV vaccine uptake in Pakistan: A qualitative study to identify barriers and facilitators before the first HPV national rollout. Human vaccines & immunotherapeutics · 3 Sept 2026 PMID 42692950
- Aotearoa New Zealanders' views of policies and funding for human papillomavirus vaccination and screening for cervical and lung cancers: a national survey. The New Zealand medical journal · 27 Aug 2026 PMID 42659668
- Age- and sex-related variation in ChatGPT-4o HPV vaccine recommendation style: A fixed-prompt audit. Human vaccines & immunotherapeutics · 21 Aug 2026 PMID 42629325
- HPV Vaccination and Risk of Head and Neck Cancers: A Large Real-World Cohort Study. International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases · 16 Aug 2026 PMID 42604649
- Simultaneous Administration of Human Papillomavirus (HPV) Vaccine With Other Recommended Vaccines Among Adolescents Aged 13-17 years, National Immunization Survey-Teen (NIS-Teen), United States, 2023. The Journal of adolescent health : official publication of the Society for Adolescent Medicine · 7 Aug 2026 PMID 42565767
- Entering into life-course immunization: Process, significance, and prospects of HPV vaccine inclusion into the national immunization program of China. Vaccine · 4 Aug 2026 PMID 42551399
- Application of an extended information-motivation-behavioral skills model to predict HPV vaccine acceptability among Chinese gay, bisexual, and other men who have sex with men. Human vaccines & immunotherapeutics · 4 Aug 2026 PMID 42550689
- Integrated service delivery to improve adolescent health and human papillomavirus (HPV) vaccination in Lao PDR: a quasi-experimental mixed-methods study - study protocol. BMJ open · 3 Aug 2026 PMID 42547242
- Mothers' intentions for adolescent sons' human papillomavirus vaccination in Japan: Psychosocial factors and relative influences across intention groups. Human vaccines & immunotherapeutics · 3 Aug 2026 PMID 42546173
- Changes in HPV vaccine hesitancy and influencing factors among female university students in China: A national repeated study. Human vaccines & immunotherapeutics · 29 Jul 2026 PMID 42525964
- Effects of a Message-Framing Video Intervention on Maternal Vaccine Confidence Regarding HPV Vaccination for Daughters: A Quasi-Experimental Study Among Mothers With Cervical Intraepithelial Neoplasia. Public health nursing (Boston, Mass.) · 23 Jul 2026 PMID 42489414
- Perceived facilitators and barriers against human papillomavirus vaccine among rural parents with eligible daughters in the Alle district, Southern Ethiopia. PloS one · 22 Jul 2026 PMID 42485289
- HPV vaccination intention and its association with vaccine hesitancy and health beliefs among unvaccinated Chinese medical college students: A cross-sectional study. PloS one · 20 Jul 2026 PMID 42475337
- HPV vaccination and the risk of cancer in males. Vaccine · 19 Jul 2026 PMID 42472496
- Shared clinical decision-making for vaccination: A view through the lens of mid-adult HPV vaccination. Human vaccines & immunotherapeutics · 8 Jul 2026 PMID 42417053
- Personal vs professional HPV vaccination and screening among female healthcare workers in China. Vaccine · 25 Jun 2026 PMID 42349131
- Infectious disease hospitalization rates before and after introduction of vaccine against human papillomavirus in Denmark, Norway, and Sweden: controlled interrupted time series analyses. Vaccine · 17 Jun 2026 PMID 42308975
- Adverse events following immunization with human papillomavirus vaccine: post-marketing surveillance in China, 2021-2024. Vaccine · 15 Jun 2026 PMID 42296833
- HPV vaccine: Influencing peer recommendations through information provision at no-cost vaccine clinics. Vaccine · 12 Jun 2026 PMID 42284811
- Understanding HPV vaccine preferences among sexual minority men living with HIV in Abuja, Nigeria using a discrete choice experiment. Vaccine · 30 May 2026 PMID 42217449
- Occupational HPV exposure and vaccination among healthcare workers: Implications for institutional vaccination strategies. Human vaccines & immunotherapeutics · 26 May 2026 PMID 42189578
- Challenges to human papillomavirus vaccination among young girls in Morocco: A national cross-sectional study. PloS one · 20 May 2026 PMID 42160355
- Population-Based First Estimates of the Effect of HPV Vaccination in Three Italian Areas Covered by Organised Cervical Screening. International journal of cancer · 5 May 2026 PMID 42084786
- Population-level prevalence and risk of oral HPV infection with or without HPV vaccination. Human vaccines & immunotherapeutics · 4 May 2026 PMID 42080318
- Geographic inequities in human papillomavirus vaccine non-uptake and its determinants among adolescent girls in Ethiopia: Evidence from the National Immunization Survey. PloS one · 28 Apr 2026 PMID 42048332
- Association a school-based educational program and human papillomavirus (HPV) vaccination uptake in France: A pilot observational study. Vaccine · 27 Apr 2026 PMID 42044612
By study type
Observational studies and case reports (12)
- Sociodemographic correlates of human papilloma virus (HPV) and cervical cancer knowledge among Saudi women: A nationwide assessment. Medicine · 2 Oct 2026 PMID 42826274
- Knowledge and attitudes of medical students about human papillomavirus (HPV) and HPV vaccine: A cross-sectional survey in Inner Mongolia, China. Human vaccines & immunotherapeutics · 28 Sept 2026 PMID 42802652
- Aotearoa New Zealanders' views of policies and funding for human papillomavirus vaccination and screening for cervical and lung cancers: a national survey. The New Zealand medical journal · 27 Aug 2026 PMID 42659668
- Application of an extended information-motivation-behavioral skills model to predict HPV vaccine acceptability among Chinese gay, bisexual, and other men who have sex with men. Human vaccines & immunotherapeutics · 4 Aug 2026 PMID 42550689
- Mothers' intentions for adolescent sons' human papillomavirus vaccination in Japan: Psychosocial factors and relative influences across intention groups. Human vaccines & immunotherapeutics · 3 Aug 2026 PMID 42546173
- Changes in HPV vaccine hesitancy and influencing factors among female university students in China: A national repeated study. Human vaccines & immunotherapeutics · 29 Jul 2026 PMID 42525964
- HPV vaccination intention and its association with vaccine hesitancy and health beliefs among unvaccinated Chinese medical college students: A cross-sectional study. PloS one · 20 Jul 2026 PMID 42475337
- HPV vaccination and the risk of cancer in males. Vaccine · 19 Jul 2026 PMID 42472496
- Personal vs professional HPV vaccination and screening among female healthcare workers in China. Vaccine · 25 Jun 2026 PMID 42349131
- Occupational HPV exposure and vaccination among healthcare workers: Implications for institutional vaccination strategies. Human vaccines & immunotherapeutics · 26 May 2026 PMID 42189578
- Challenges to human papillomavirus vaccination among young girls in Morocco: A national cross-sectional study. PloS one · 20 May 2026 PMID 42160355
- Association a school-based educational program and human papillomavirus (HPV) vaccination uptake in France: A pilot observational study. Vaccine · 27 Apr 2026 PMID 42044612
Human data, design not indexed (17)
- Health care providers' perspectives on county-level barriers and facilitators to HPV vaccination: A socio-ecological approach (2022-2023). Human vaccines & immunotherapeutics · 5 Oct 2026 PMID 42832184
- Real-world safety data of human papillomavirus vaccines after marketing in Shandong, China, August 2017-October 2025. Human vaccines & immunotherapeutics · 25 Sept 2026 PMID 42788243
- Global policy determinants of national human papillomavirus vaccine introductions in 2006-2025. Expert review of vaccines · 22 Sept 2026 PMID 42770688
- HPV vaccine uptake in Pakistan: A qualitative study to identify barriers and facilitators before the first HPV national rollout. Human vaccines & immunotherapeutics · 3 Sept 2026 PMID 42692950
- Age- and sex-related variation in ChatGPT-4o HPV vaccine recommendation style: A fixed-prompt audit. Human vaccines & immunotherapeutics · 21 Aug 2026 PMID 42629325
- Simultaneous Administration of Human Papillomavirus (HPV) Vaccine With Other Recommended Vaccines Among Adolescents Aged 13-17 years, National Immunization Survey-Teen (NIS-Teen), United States, 2023. The Journal of adolescent health : official publication of the Society for Adolescent Medicine · 7 Aug 2026 PMID 42565767
- Entering into life-course immunization: Process, significance, and prospects of HPV vaccine inclusion into the national immunization program of China. Vaccine · 4 Aug 2026 PMID 42551399
- Integrated service delivery to improve adolescent health and human papillomavirus (HPV) vaccination in Lao PDR: a quasi-experimental mixed-methods study - study protocol. BMJ open · 3 Aug 2026 PMID 42547242
- Effects of a Message-Framing Video Intervention on Maternal Vaccine Confidence Regarding HPV Vaccination for Daughters: A Quasi-Experimental Study Among Mothers With Cervical Intraepithelial Neoplasia. Public health nursing (Boston, Mass.) · 23 Jul 2026 PMID 42489414
- Perceived facilitators and barriers against human papillomavirus vaccine among rural parents with eligible daughters in the Alle district, Southern Ethiopia. PloS one · 22 Jul 2026 PMID 42485289
- Shared clinical decision-making for vaccination: A view through the lens of mid-adult HPV vaccination. Human vaccines & immunotherapeutics · 8 Jul 2026 PMID 42417053
- Infectious disease hospitalization rates before and after introduction of vaccine against human papillomavirus in Denmark, Norway, and Sweden: controlled interrupted time series analyses. Vaccine · 17 Jun 2026 PMID 42308975
- Adverse events following immunization with human papillomavirus vaccine: post-marketing surveillance in China, 2021-2024. Vaccine · 15 Jun 2026 PMID 42296833
- HPV vaccine: Influencing peer recommendations through information provision at no-cost vaccine clinics. Vaccine · 12 Jun 2026 PMID 42284811
- Understanding HPV vaccine preferences among sexual minority men living with HIV in Abuja, Nigeria using a discrete choice experiment. Vaccine · 30 May 2026 PMID 42217449
- Population-level prevalence and risk of oral HPV infection with or without HPV vaccination. Human vaccines & immunotherapeutics · 4 May 2026 PMID 42080318
- Geographic inequities in human papillomavirus vaccine non-uptake and its determinants among adolescent girls in Ethiopia: Evidence from the National Immunization Survey. PloS one · 28 Apr 2026 PMID 42048332
Unclassified: not yet indexed with MeSH (2)
- HPV Vaccination and Risk of Head and Neck Cancers: A Large Real-World Cohort Study. International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases · 16 Aug 2026 PMID 42604649
- Population-Based First Estimates of the Effect of HPV Vaccination in Three Italian Areas Covered by Organised Cervical Screening. International journal of cancer · 5 May 2026 PMID 42084786
Written from 31 PubMed abstracts, each one listed by PMID above. Published: 2026-08-14. Last written: 2026-09-26 by GPT. Drafted by language models from published abstracts; not medical advice.